Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

News Conference News AHA 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Shelley Wood

November 11, 2019

News Conference News TCT 2019

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Michael O'Riordan

September 27, 2019

News Daily News

Elevated BP Linked to Risk of Valvular Heart Disease, Including Aortic Stenosis

Michael O'Riordan

July 12, 2019

News Daily News

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Michael O'Riordan

July 10, 2019

News Industry News

Cordis Continues to Expand Interventional Cardiology Portfolio with Radial Offering

May 14, 2019

News Daily News

First US Consensus Statement on PFO Closure Addresses Volume Requirements, Quality Measurements

Yael L. Maxwell

April 01, 2019

News Daily News

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Michael O'Riordan

March 27, 2019

News Daily News

Late Follow-up of PFO Closure for Stroke Raises Questions for Antiplatelet Duration

Shelley Wood

January 22, 2019

Manuscript

Occurrence and Classification of Cerebrovascular Events after Isolated Bioprosthetic Surgical Aortic Valve Replacement: A Competing Risk Analysis of the CAREAVR Study

January 03, 2018

Advertisement

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Elevated BP Linked to Risk of Valvular Heart Disease, Including Aortic Stenosis

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Cordis Continues to Expand Interventional Cardiology Portfolio with Radial Offering

First US Consensus Statement on PFO Closure Addresses Volume Requirements, Quality Measurements

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Late Follow-up of PFO Closure for Stroke Raises Questions for Antiplatelet Duration

Occurrence and Classification of Cerebrovascular Events after Isolated Bioprosthetic Surgical Aortic Valve Replacement: A Competing Risk Analysis of the CAREAVR Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content